Daniele Pastori | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis	BRITISH JOURNAL OF CLINICAL PHARMACOLOGY	2022
Cardiac and vascular features of arterial and venous primary antiphospholipid syndrome. The multicenter ATHERO-APS study	THROMBOSIS RESEARCH	2022
Plasma homocysteine in Behcet's disease: a systematic review and meta-analysis	THROMBOSIS AND HAEMOSTASIS	2022
REPLY to “Association Between Plasmatic Oxidative Stress and Thrombosis in Primary Antiphospholipid Syndrome”	JOURNAL OF THROMBOSIS AND THROMBOLYSIS	2022
Added fructose in non-alcoholic fatty liver disease and in metabolic sindrome. a narrative review	NUTRIENTS	2022
A Meta-Analysis of Plasma Homocysteine in Buerger's Disease	THROMBOSIS AND HAEMOSTASIS	2022
Thrombotic aspects of SARS-CoV-2 infection: indications for treatment	ITALIAN JOURNAL OF EMERGENCY MEDICINE	2022
Aging-Related Decline of Autophagy in Patients with Atrial Fibrillation—A Post Hoc Analysis of the ATHERO-AF Study	ANTIOXIDANTS	2022
Mediterranean Diet: A Tool to Break the Relationship of Atrial Fibrillation with the Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease	NUTRIENTS	2022
Metabolic syndrome but not fatty liver-associated genetic variants correlates with glomerular renal function decline in patients with non-alcoholic fatty liver disease	BIOMEDICINES	2022
Bleeding and mortality risk in patients implanted with mechanical prosthetic heart valves with and without thrombocytopenia. Insights from the nationwide PLECTRUM registry	PLATELETS	2022
Clinical phenotypes of atrial fibrillation and mortality risk-a cluster analysis from the nationwide italian START registry	JOURNAL OF PERSONALIZED MEDICINE	2022
Fibrosis-4 (FIB-4) index and mortality in COVID-19 patients admitted to the emergency department	INTERNAL AND EMERGENCY MEDICINE	2022
Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in primary antiphospholipid syndrome. the multicenter ATHERO-APS study	JOURNAL OF AUTOIMMUNITY	2022
Characteristics of patients with atrial high rate episodes detected by implanted defibrillator and resynchronization devices	EUROPACE	2022
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF). a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study	THE LANCET	2022
Prevention and management of type ii diabetes chronic complications. the role of polyphenols (mini-review)	CURRENT MEDICINAL CHEMISTRY	2022
The sodium–glucose co-transporter-2 (SGLT2) inhibitors reduce platelet activation and thrombus formation by lowering NOX2-related oxidative stress: a pilot study	ANTIOXIDANTS	2022
Intima media thickness of carotid arteries in familial Mediterranean fever: a systematic review and meta-analysis	CLINICAL RHEUMATOLOGY	2022
Heterogeneity of non-alcoholic fatty liver disease (NAFLD): implication for cardiovascular risk stratification	ATHEROSCLEROSIS	2022

ERC

LS4
LS4_10
LS7
LS7_10

Keywords

cardiovascular disease

anticoagulation

Novel oral anticoagulants

atrial fibrillation

atherosclerosis

NAFLD

NASH

antiphospholipid antibody syndrome

ischemic heart disease

cardiovascular risk

Thrombosis

Atherothrombosis

Progetti di Ricerca

Liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome
Relationship between PCSK9 levels and major cardiovascular and cerebrovascular events (MACCE) in patients with non-alcoholic fatty liver disease (NAFLD): a prospective cohort study.